<DOC>
	<DOC>NCT00425256</DOC>
	<brief_summary>This 8 week at home study is designed to explore efficacy endpoints and evaluate the safety of intranasal Bremelanotide in women with Female Sexual Arousal Disorder. Efficacy will be assessed vs. a parallel placebo group.</brief_summary>
	<brief_title>Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)</brief_title>
	<detailed_description />
	<mesh_term>Sexual Dysfunctions, Psychological</mesh_term>
	<mesh_term>alpha-MSH</mesh_term>
	<criteria>Post menopausal and in general good health In a stable relationship with a male partner for at least 6 months Willing to attempt sexual activity once a week with your partner</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>